Table 2.
Univariate and multivariate Cox proportional hazard analysis of factors associated with recurrence in the training cohort
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| HR(95% CI) | P value | HR(95% CI) | P value | |
| Sex | 1.130 (0.601–2.124) | 0.705 | NA | NA |
| Age | 0.940 (0.612–1.446) | 0.780 | NA | NA |
| Tumor number | 0.910(0.536–1.543) | 0.725 | NA | NA |
| Tumor size | 1.025(0.667–1.576) | 0.910 | NA | NA |
| Tumor encapsulation | 1.115(0.727–1.710) | 0.617 | NA | NA |
| Satellite lesion | 1.090(0.580–2.049) | 0.789 | NA | NA |
| Vascular invasion | 0.899(0.575–1.375) | 0.596 | NA | NA |
| Tumor grade | 1.092(0.714–1.671) | 0.685 | NA | NA |
| Child-Pugh grade | 1.785(0.824–3.865) | 0.142 | NA | NA |
| BCLC stage | 0.606(0.361–1.017) | 0.058 | NA | NA |
| AFP | 0.906 (0.563–1.456) | 0.682 | NA | NA |
| ALT | 0.627(0.230–1.709) | 0.362 | NA | NA |
| GGT | 1.004(1.002–1.005) | 0.001 | 1.986(1.308–3.017) | 0.001 |
| HbsAg | 1.612(0.780–3.333) | 0.198 | NA | NA |
| HDLPO | 0.526(0.322–0.858) | 0.010 | 0.519(0.318–0.848) | 0.009 |
Note:HR is hazard ratio Abbreviation: NA,not applicable